May 26, 2022
Eli Lilly & Co. says an Indiana federal judge wrongly found that a nationwide drug discount program requires pharmaceutical companies to provide those discounted drugs to certain types of pharmacies, saying the outcome of an appeal at the Seventh Circuit would carry "profound consequences."
June 18, 2021
Following a court defeat, the U.S. Department of Health and Human Services late Friday told federal courts that it has withdrawn its December finding that drug manufacturers can't limit the number of pharmacies eligible to fill government-set, capped-cost prescriptions for eligible organizations.
May 28, 2021
An Indiana federal court extended the deadline for Eli Lilly to respond to the U.S. Department of Health and Human Services' letter warning it would be fined unless it begins offering discounts to certain pharmacies working with hospitals in low-income areas.
May 24, 2021
Eli Lilly and Co. says that the U.S. Department of Health and Human Services shouldn't be able to punish it for not offering drug discounts to pharmacies that contract with hospitals in low-income areas, saying the government is trying to find a way around a legal challenge launched by the drugmaker.
March 16, 2021
An Indiana federal judge on Tuesday granted Eli Lilly and Co.'s bid to preliminarily block the U.S. Department of Health and Human Services from deciding what discounts the drugmaker owes pharmacies that contract with hospitals in low-income areas.
February 17, 2021
The U.S. Department of Health and Human Services has shot back at Eli Lilly and Co.'s attempt to block the agency from deciding what discounts the drugmaker owes pharmacies that contract with hospitals in low-income areas.
January 26, 2021
Eli Lilly and Co. wants an Indiana federal judge to block the U.S. Department of Health and Human Services from deciding what discounts the drugmaker owes pharmacies that contract with hospitals in low-income areas, accusing HHS of pursuing a "dubious scheme" that will "penalize Lilly to the tune of billions of dollars."
January 13, 2021
AstraZeneca, Eli Lilly and Sanofi-Aventis have launched a series of lawsuits challenging the U.S. Department of Health and Human Services' view that drugmakers have to give discounts to pharmacies contracting with hospitals that participate in a program serving low-income areas.